300858 科拓生物
按盤價 
14.350 +0.090 (+0.631%)
14.350 +0.090 (+0.631%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.381 | 5.204 | 5.357 | 5.451 | 8.250 |
| 總資產報酬率 ROA (%) | 1.240 | 4.805 | 5.065 | 5.191 | 7.760 |
| 投入資產回報率 ROIC (%) | 1.365 | 5.137 | 5.268 | 5.361 | 8.085 | 邊際利潤分析 |
| 銷售毛利率 (%) | 47.089 | 51.503 | 58.252 | 54.582 | 51.975 |
| 營業利潤率 (%) | 16.077 | 28.586 | 36.151 | 34.287 | 34.558 |
| 息稅前利潤/營業總收入 (%) | 13.541 | 22.988 | 27.858 | 26.262 | 33.175 |
| 淨利潤/營業總收入 (%) | 14.806 | 25.830 | 31.162 | 31.239 | 29.767 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 80.891 | 92.056 | 83.943 | 87.848 | 89.411 |
| 價值變動淨收益/利潤總額(%) | 23.036 | 3.660 | 5.138 | 7.237 | 7.433 |
| 營業外收支淨額/利潤總額(%) | 0.009 | -0.745 | -0.583 | -0.549 | -1.529 | 償債能力分析 |
| 流動比率 (X) | 4.545 | 7.659 | 9.925 | 16.296 | 15.560 |
| 速動比率 (X) | 4.260 | 7.295 | 9.441 | 15.627 | 14.963 |
| 資產負債率 (%) | 11.644 | 8.722 | 6.579 | 4.259 | 5.308 |
| 帶息債務/全部投入資本 (%) | -1.395 | -1.556 | -0.080 | 0.737 | 0.966 |
| 股東權益/帶息債務 (%) | -7,074.937 | -6,359.979 | -122,902.593 | 13,323.437 | 10,189.120 |
| 股東權益/負債合計 (%) | 758.830 | 1,046.581 | 1,419.955 | 2,247.741 | 1,783.798 |
| 利息保障倍數 (X) | -5.337 | -4.267 | -3.446 | -3.350 | -38.431 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 75.605 | 61.753 | 72.447 | 101.453 | 106.466 |
| 存貨周轉天數 (天) | 100.140 | 94.396 | 122.204 | 119.403 | 105.367 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
